FABP3 and metabolic syndrome: For instance, Akbal et al. [13] reported that serum H-FABP levels were significantly higher in diabetic patients with MetS than patients without diabetic MetS, indicating its promise as a marker for detection of cardiac injury during the early asymptomatic period in diabetic patients.